基本情報
- 標準SMILES
CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1- InChIKey
ZJKNESGOIKRXQY-UHFFFAOYSA-N- 分子式
- C12H12N2O2S
- 平均分子量
- 248.3 g/mol
- 単同位体質量
- 248.06194862
概要
Enoximone is an aromatic ketone.
名称と識別子
- 優先名称
- Enoximone
- IUPAC
- 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one
- 現地名
- エノキシモン
- 英語名
- Enoximone
- 分子式
- C12H12N2O2S
- 分子量
- 248.3
名称と別名
名称をさらに表示
データベース識別子
- CAS
77671-31-9- PubChem CID
- 53708
- DTXSID
DTXSID8045147- ChEMBL
CHEMBL249856- ChEBI
CHEBI:135010- UNII
- C7Z4ITI7L7
- EC Number
- 989-259-7
- Nikkaji
- J22.780C
物性
構造計算による物性
- XLogP
- 1.6
- 極性表面積
- 83.5 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 3
- 回転可能結合数
- 3
- 重原子数
- 17
- 形式電荷
- 0
- 複雑度
- 371
実験および物理化学的性質
物理化学的性質
- 融点
- 255 · 255-258°C
- 比重(密度)
- 1.33 · 1.33
- 貯蔵温度
- Sealed in dry,Room Temperature
- 溶解性
- 28 mg/mL、可溶 · DMSO: 28 mg/mL、可溶
- 酸解離定数(Pka)
- 10.37 · 10.37±0.70(Predicted)
- 外見
- 個体
- 色
- ライトイエロー
- InChI
- 1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16)
- InChIKey
- ZJKNESGOIKRXQY-UHFFFAOYSA-N
- SMILES
- CSc1ccc(cc1)C(=O)C2=C(C)NC(=O)N2
- CAS データベース
- 77671 · 77671-31-9(CAS DataBase Reference)
安全と法規制
GHS分類
危険有害性情報
安全データ
- wgk
- 3
- ridadr
- 3249
- hazard_class
- 6.1(b)
- packing_group
- III
- ストレージクラス
- 10 - Combustible liquids
化学と産業
薬理情報
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
Pharmacodynamics
Enoximone is a phosphodiesterase inhibitor (type III) that increases the force of contraction of the heart and dilates blood vessels. In June 2005, Myogen announced that they were discontinuing development of enoximone due to negative results. The drug is approved for use in the UK.
Mechanism of Action
Further research is required to determine accurately the mechanism of action of drugs with phosphodiesterase inhibitory activity, however, inhibition of PDE3 inhibits degredation of cGMP. This allows for increased NO release and vascular relaxation.
MeSH Pharmacological Classification
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
Drugs used to cause dilation of the blood vessels.
Compounds that specifically inhibit PHOSPHODIESTERASE 3.
応用分野
説明Enoximone is a phosphodiesterase inhibitor indicated for selective use as a cardiostimulant in heart transplant patient maintenance. It is currently being investigated for other indications including acute congestive heart failure.
使用Enoximone is a phosphodiesterase inhibitor used in the treatment of congestive heart failure and is selective to phosphodiesterase 3. Potent PDE-3 inhibitor.
上流・下流製品情報
上流原料
サプライヤー49 社
関連反応
現在のフィルター条件では反応記録がありません。
関連ノート
読み込み中…